Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer

    NEXT STORY
    Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
    PREV STORY
    Cue Biopharma Reports Third Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CalciMedica Announces Publication of Preclinical Data Demonstrating the Pathological Role of Microglial CRAC Channels in Ischemic Stroke

    author_avatar
    NASDAQ Market News

    Roche’s marketing applications for satralizumab in neuromyelitis optica spectrum disorder accepted for review by EMA and FDA

    author_avatar
    NASDAQ Market News

    Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020

    author_avatar
    NASDAQ Market News